In the Face of Complete Genomics' Competition, Global Financial Crisis, Genome Corp Closes Doors

Having raised $750,000 in startup funding, Genome Corp lost its prospective Series A lead investor last fall after Complete Genomics revealed a similar business model and faster commercialization plans.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.